全文获取类型
收费全文 | 4425篇 |
免费 | 270篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 148篇 |
妇产科学 | 120篇 |
基础医学 | 614篇 |
口腔科学 | 43篇 |
临床医学 | 588篇 |
内科学 | 795篇 |
皮肤病学 | 65篇 |
神经病学 | 456篇 |
特种医学 | 103篇 |
外科学 | 495篇 |
综合类 | 39篇 |
一般理论 | 3篇 |
预防医学 | 538篇 |
眼科学 | 40篇 |
药学 | 298篇 |
中国医学 | 4篇 |
肿瘤学 | 332篇 |
出版年
2023年 | 48篇 |
2022年 | 47篇 |
2021年 | 157篇 |
2020年 | 103篇 |
2019年 | 130篇 |
2018年 | 137篇 |
2017年 | 86篇 |
2016年 | 109篇 |
2015年 | 114篇 |
2014年 | 172篇 |
2013年 | 242篇 |
2012年 | 358篇 |
2011年 | 414篇 |
2010年 | 192篇 |
2009年 | 198篇 |
2008年 | 302篇 |
2007年 | 323篇 |
2006年 | 301篇 |
2005年 | 241篇 |
2004年 | 251篇 |
2003年 | 207篇 |
2002年 | 177篇 |
2001年 | 28篇 |
2000年 | 21篇 |
1999年 | 26篇 |
1998年 | 27篇 |
1997年 | 29篇 |
1996年 | 20篇 |
1995年 | 26篇 |
1994年 | 21篇 |
1993年 | 19篇 |
1992年 | 15篇 |
1991年 | 12篇 |
1990年 | 20篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 11篇 |
1986年 | 8篇 |
1985年 | 11篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 9篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1976年 | 7篇 |
1975年 | 6篇 |
1974年 | 4篇 |
1968年 | 4篇 |
排序方式: 共有4714条查询结果,搜索用时 15 毫秒
991.
Melinda L. Toumi Eden P. Go Heather Desaire 《Journal of pharmaceutical sciences》2009,98(8):2581-2591
Recombinant glycoproteins present unique challenges to biopharmaceutical development, especially when efficacy is affected by glycosylation. In these cases, optimizing the protein's glycosylation is necessary, but difficult, since the glycan structures cannot be genetically encoded, and glycosylation in nonhuman cell lines can be very different from human glycosylation profiles. We are exploring a potential solution to this problem by designing enzymatic glycan optimization methods to produce proteins with useful glycan compositions. To demonstrate viability of this new approach to generating glycoprotein-based pharmaceuticals, the N-linked glycans of a model glycoprotein, ribonuclease B (RNase B), were modified using an α-mannosidase to produce a new glycoprotein with different glycan structures. The secondary structure of the native and modified glycoproteins was retained, as monitored using circular dichroism. An assay was also developed using an RNA substrate to verify that RNase B had indeed retained its function after being subjected to the necessary glycan modification conditions. This is the first study that verifies both activity and secondary structure of a glycoprotein after enzymatic glycan trimming for use in biopharmaceutical development methods. The evidence of preserved structure and function for a modified glycoprotein indicates that extracellular enzymatic modification methods could be implemented in producing designer glycoproteins. © 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2581–2591, 2009 相似文献
992.
Honglin Chen Chung Lam Cheung Hung Tai Pengxi Zhao Jasper F.W. Chan Vincent C.C. Cheng Kwok-Hung Chan Kwok-Yung Yuen 《Emerging infectious diseases》2009,15(12):1970-1972
Resistance to oseltamivir was observed in influenza A pandemic (H1N1) 2009 virus isolated from an untreated person in Hong Kong, China. Investigations showed a resistant virus with the neuraminidase (NA) 274Y genotype in quasi-species from a nasopharyngeal aspirate. Monitoring for the naturally occurring NA 274Y mutation in this virus is necessary. 相似文献
993.
994.
995.
Melinda B. Davis Jennifer Jarvie Ellise Gambahaya Joann Lindenfeld David Kao 《Journal of cardiac failure》2021,27(2):159-167
BackgroundPeripartum cardiomyopathy (PPCM) causes significant morbidity and mortality in childbearing women. Delays in diagnosis lead to worse outcomes; however, no validated risk prediction model exists. We sought to validate a previously described model and identify novel risk factors for PPCM presenting at the time of delivery.Methods and ResultsAdministrative hospital records from 5,277,932 patients from 8 states were screened for PPCM, identified by International Classification of Disease-9 Clinical Modification codes (674.5x) at the time of delivery. Demographics, comorbidities, procedures, and outcomes were quantified. Performance of a previously published regression model alone and with the addition of novel PPCM-associated characteristics was assessed using receiver operating characteristic area under the curve (AUC) analysis. Novel risk factors were identified using multivariate logistic regression and the likelihood ratio test. In total, 1186 women with PPCM were studied, including 535 of 4,003,912 delivering mothers (0.013%) in the derivation set compared with 651 of 5,277,932 (0.012%) in the validation set. The previously published risk prediction model performed well in both the derivation (area under the curve 0.822) and validation datasets (area under the curve 0.802). Novel PPCM-associated characteristics in the combined cohort included diabetes mellitus (odds ratio [OR] of PPCM 1.93, 95% confidence interval [CI] 1.23–3.02, P = .004), mood disorders (OR 1.74, 95% CI 1.22–2.47, P = .002), obesity (OR 1.92, 95% CI 1.45–2.55, P < .001), and Medicaid insurance (OR 1.54, 95% CI 1.22-1.96, P < .001).ConclusionsThis is the first validated risk prediction model to identify women at increased risk for PPCM at the time of delivery. Diabetes mellitus, obesity, mood disorders, and lower socioeconomic status are risk factors associated with PPCM. This model may be useful for identifying women at risk and preventing delays in diagnosis. 相似文献
996.
997.
999.
1000.
Saleh Yazdani Jasper Callemeyn Stéphane Gazut Evelyne Lerut Henriette de Loor Max Wevers Line Heylen Carole Saison Alice Koenig Olivier Thaunat Lieven Thorrez Dirk Kuypers Ben Sprangers Laure-Hélène Noël Leentje Van Lommel Frans Schuit Marie Essig Wilfried Gwinner Maarten Naesens 《Kidney international》2019,95(1):188-198